Actively Recruiting
Homologous PRP vs Placebo in Knee Osteoarthritis in Over 65 Years Old Patients
Led by Istituto Ortopedico Rizzoli · Updated on 2025-08-03
204
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to compare the 6 months clinical outcome of the treatment with a single injection of Homologous PRP versus single injection of placebo (saline solution) in the infiltrative treatment of knee osteoarthritis in over 65 years old patients. The evaluation will be performed through clinical, subjective and objective assessments.
CONDITIONS
Official Title
Homologous PRP vs Placebo in Knee Osteoarthritis in Over 65 Years Old Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Unilateral involvement of knee osteoarthritis
- Signs and symptoms of degenerative knee cartilage disease
- Radiographic or MRI evidence of knee cartilage degeneration (Kellgren-Lawrence grades 1 to 4)
- Ability and willingness to participate in clinical follow-up visits
- Signed informed consent
You will not qualify if you...
- Knee surgery within the past 12 months
- Presence of malignant tumors
- Rheumatic diseases
- Diabetes
- Blood clotting disorders or hematologic diseases
- Thyroid metabolic disorders
- Abuse of alcohol, drugs, or medications
- Body Mass Index over 35
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136
Actively Recruiting
Research Team
R
Roberta Licciardi, Msc
CONTACT
A
Alessandro Di Martino, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here